Cathie's Ark Logo
undefined Logo

ARKG Holdings of CRISPR Therapeutics (CRSP) - Updated Daily

TherapeuticsGene TherapyCAR-T Cell TherapyCRSPR Gene Editing
Date
Direction
Shares
Fund Weight
Fund
May 21, 2024
BUY26.694k0.0999%ARKG
May 10, 2024
BUY15.727k0.0592%ARKG
May 9, 2024
BUY10.729k0.0408%ARKG
April 9, 2024
BUY2.893k0.0123%ARKG
April 8, 2024
BUY19.447k0.0823%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
7.37%$4.92b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
1🇨🇭Switzerland
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
3$70.01
🎫ARK Ownership Percent
2.12%

Other ETFs That Hold CRSP

Ticker
NameWeight
ARKGARK Genomic Revolution ETF3.7%
GNOMGlobal X Genomics & Biotechnology ETF3.52%
ARKKARK Innovation ETF3.37%
XBISPDR® S&P Biotech ETF1.01%
IBBiShares Biotechnology ETF0.35%
LABUS&P Biotech Bull 3X Shares ETF0.242%

Research Notes and Commentary for CRSP

No Research Notes Found for CRSP